Cargando…
Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) kinetics remain understudied, including the impact of remdesivir. In hospitalized individuals, peak sputum viral load occurred in week 2 of symptoms, whereas viremia peaked within 1 week of symptom-onset, suggesting early systemic seeding...
Autores principales: | Regan, James, Flynn, James P, Rosenthal, Alexandra, Jordan, Hannah, Li, Yijia, Chishti, Rida, Giguel, Francoise, Corry, Heather, Coxen, Kendyll, Fajnzylber, Jesse, Gillespie, Elizabeth, Kuritzkes, Daniel R, Hacohen, Nir, Goldberg, Marcia B, Filbin, Michael R, Yu, Xu G, Baden, Lindsey, Ribeiro, Ruy M, Perelson, Alan S, Conway, Jessica M, Li, Jonathan Z |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083268/ https://www.ncbi.nlm.nih.gov/pubmed/34430669 http://dx.doi.org/10.1093/ofid/ofab153 |
Ejemplares similares
-
Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19
por: Li, Yijia, et al.
Publicado: (2020) -
SARS-CoV-2 viral load is associated with increased disease severity and mortality
por: Fajnzylber, Jesse, et al.
Publicado: (2020) -
Increased Prevalence of Myocardial Injury in Patients with SARS-CoV-2 Viremia
por: Siddiqi, Hasan K., et al.
Publicado: (2021) -
The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia
por: Wang, Chuangqi, et al.
Publicado: (2022) -
Opioid use does not limit potent low-dose HIV-1 latency reversal agent boosting
por: Lilie, Tyler, et al.
Publicado: (2023)